WTW

Willis Towers Watson Public
D

WTW

Arincen67/100B

Willis Towers Watson Public executives and insider trading

Carl A. Hess CERA reported no open-market purchases or sales over the last twelve months.

Over the last twelve months Willis Towers Watson Public's insiders sold 3,730 shares for 1.16M USD in 2 sales on the open market, and bought 7,637 shares in 4 purchases.

Insiders over the last twelve months

Insider sales
2
Shares sold
3,730
Value sold
1.16M USD
Insider purchases
4

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
0
3 months
250.17K USD
0
6 months
250.17K USD
2.07M USD
1 year
1.16M USD
2.07M USD
2 years
6.52M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Lucy Clarke President of Risk & Broking59——5,396——
Matthew S. Furman General Counsel563,000912.01K USD—3 Mar 2026—
Carl Aaron Hess Director, Chief Executive Officer———2,000——
Alexis Faber Chief Operating Officer48730250.17K USD—10 Aug 2026—
Michael P. Hammond Director———241——

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
10 Aug 2026Alexis FaberSale730342.70250.17K USD10,752Form 4
6 May 2026Lucy ClarkePurchase1,896263.37499.34K USD22,717Form 4
4 May 2026Carl Aaron HessPurchase2,000255.08510.16K USD117,425Form 4
3 Mar 2026Matthew S. FurmanSale3,000304.00912.01K USD38,185Form 4
13 Feb 2026Lucy ClarkePurchase3,500284.84996.93K USD19,250Form 4
12 Feb 2026Michael P. HammondPurchase241278.8667.21K USD2,505Form 4
3 Jun 2025Andrew Jay KrasnerSale1,600315.75505.20K USD11,982Form 4
8 May 2025Carl Aaron HessSale146306.8544.80K USD95,838Form 4
8 May 2025Carl Aaron HessSale192307.9159.12K USD95,646Form 4
8 May 2025Carl Aaron HessSale6,062308.781.87M USD89,584Form 4
8 May 2025Carl Aaron HessSale2,891309.67895.26K USD86,693Form 4
8 May 2025Carl Aaron HessSale709310.74220.31K USD85,984Form 4
8 May 2025Alexis FaberSale265306.9281.33K USD7,981Form 4
3 Mar 2025Julie Jarecke GebauerSale1,616338.74547.40K USD72,793Form 4
28 Feb 2025Julie Jarecke GebauerSale3,384335.771.14M USD74,417Form 4

Common questions about Willis Towers Watson Public's executives and insiders

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.